T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
THI
351
DELISTED
TIM HORTONS INC COM, CANADA
THI
| $294M | 0.06% |
5,366,318
-501,497
| -9% | -$27.5M |
|
|
ATHL
352
DELISTED
ATHLON ENERGY INC COM
ATHL
| $292M | 0.06% |
6,124,836
+4,671,637
| +321% | +$196M |
|
353
Dollar General
DG
$26.2B
| $292M | 0.06% |
5,088,795
-3,512,670
| -41% | -$201M |
|
354
First American
FAF
$7.36B
| $292M | 0.06% |
10,502,297
+25,085
| +0.2% | +$684K |
|
355
Sprouts Farmers Market
SFM
$7.8B
| $291M | 0.06% |
8,905,136
+713,635
| +9% | +$22.2M |
|
356
Herc Holdings
HRI
$5.7B
| $291M | 0.06% |
3,458,613
-788,805
| -19% | -$66.5M |
|
357
NOV
NOV
$7.41B
| $290M | 0.06% |
3,526,207
+2,078,976
| +144% | +$155M |
|
358
Occidental Petroleum
OXY
$58.7B
| $290M | 0.06% |
2,946,305
+1,568
| +0.1% | +$147K |
|
|
DO
359
DELISTED
Diamond Offshore Drilling
DO
| $289M | 0.06% |
5,815,352
+361,630
| +7% | +$18M |
|
|
AWAY
360
DELISTED
HOMEAWAY INC COM
AWAY
| $285M | 0.06% |
8,173,699
+7,498,470
| +1,111% | +$247M |
|
|
WBC
361
DELISTED
WABCO HOLDINGS INC.
WBC
| $284M | 0.06% |
2,660,795
-577,968
| -18% | -$61.9M |
|
362
Sun Life Financial
SLF
$44.8B
| $283M | 0.06% |
7,699,200
+602,700
| +8% | +$20.8M |
|
363
Genuine Parts
GPC
$18.4B
| $283M | 0.06% |
3,220,391
-7,300
| -0.2% | -$628K |
|
364
DaVita
DVA
$11.4B
| $281M | 0.06% |
3,885,661
+1,254,731
| +48% | +$87.3M |
|
|
P
365
DELISTED
Pandora Media Inc
P
| $281M | 0.06% |
9,522,258
+7,445,804
| +359% | +$194M |
|
|
CIT
366
DELISTED
CIT Group Inc.
CIT
| $280M | 0.06% |
6,117,283
+1,372,147
| +29% | +$61.9M |
|
367
MDU Resources
MDU
$4.35B
| $280M | 0.06% |
20,947,473
+2,182,925
| +12% | +$28.5M |
|
368
East-West Bancorp
EWBC
$18.3B
| $278M | 0.06% |
7,942,553
-111,568
| -1% | -$3.87M |
|
369
Lumen
LUMN
$6.53B
| $277M | 0.06% |
7,655,981
-16,510
| -0.2% | -$593K |
|
370
McDonald's
MCD
$192B
| $276M | 0.06% |
2,743,333
-9,100
| -0.3% | -$919K |
|
371
Automatic Data Processing
ADP
$106B
| $275M | 0.06% |
3,954,688
+73,318
| +2% | +$5M |
|
372
Norfolk Southern
NSC
$74.9B
| $274M | 0.06% |
2,663,345
-2,839,713
| -52% | -$279M |
|
373
Quanta Services
PWR
$104B
| $272M | 0.06% |
7,874,141
-9,874,620
| -56% | -$342M |
|
374
Nordson
NDSN
$17.4B
| $272M | 0.06% |
3,392,050
-21,800
| -0.6% | -$1.68M |
|
375
SL Green Realty
SLG
$3.97B
| $270M | 0.06% |
2,551,841
-3,771
| -0.1% | -$390K |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.